The DOI matches its Crossref record; 369 of the 369 references it cites were found in a registry or an index.
Basic Mechanisms of Diabetic Heart Disease
Open accessAbstract
Diabetes mellitus predisposes affected individuals to a significant spectrum of cardiovascular complications, one of the most debilitating in terms of prognosis is heart failure. Indeed, the increasing global prevalence of diabetes mellitus and an aging population has given rise to an epidemic of diabetes mellitus–induced heart failure. Despite the significant research attention this phenomenon, termed diabetic cardiomyopathy, has received over several decades, understanding of the full spectrum of potential contributing mechanisms, and their relative contribution to this heart failure phenotype in the specific context of diabetes mellitus, has not yet been fully resolved. Key recent preclinical discoveries that comprise the current state-of-the-art understanding of the basic mechanisms of the complex phenotype, that is, the diabetic heart, form the basis of this review. Abnormalities in each of cardiac metabolism, physiological and pathophysiological signaling, and the mitochondrial compartment, in addition to oxidative stress, inflammation, myocardial cell death pathways, and neurohumoral mechanisms, are addressed. Further, the interactions between each of these contributing mechanisms and how they align to the functional, morphological, and structural impairments that characterize the diabetic heart are considered in light of the clinical context: from the disease burden, its current management in the clinic, and where the knowledge gaps remain. The need for continued interrogation of these mechanisms (both known and those yet to be identified) is essential to not only decipher the how and why of diabetes mellitus–induced heart failure but also to facilitate improved inroads into the clinical management of this pervasive clinical challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Myocardial Remodeling in Diabetic Cardiomyopathy Associated with Cardiac Mast Cell Activation
Huang, Z. G., Jin, Q., Fan, M., Cong, X. L., Han, S. F., Gao, H., & Shan, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060827 · Cited by 38
RetractedEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31149-3 · Cited by 3,163
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Biological Functions of Autophagy Genes: A Disease Perspective
Levine, B., & Kroemer, G. (2019) · Cell · doi:10.1016/j.cell.2018.09.048 · Cited by 2,832
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Pieske, B., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., Edelmann, F., Fu, M., Guazzi, M., Lam, C. S. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz641 · Cited by 1,855
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
Epidemiology of heart failure with preserved ejection fraction
Dunlay, S. M., Roger, V. L., & Redfield, M. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.65 · Cited by 1,534
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Obokata, M., Reddy, Y. N. V., Pislaru, S. V., Melenovsky, V., & Borlaug, B. A. (2017) · Circulation · doi:10.1161/circulationaha.116.026807 · Cited by 1,179
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
Swirski, F. K., & Nahrendorf, M. (2013) · Science · doi:10.1126/science.1230719 · Cited by 1,086
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Verma, S., & McMurray, J. J. V. (2018) · Diabetologia · doi:10.1007/s00125-018-4670-7 · Cited by 999
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Jia, G., DeMarco, V. G., & Sowers, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.216 · Cited by 949
Impact of Diabetes on Cardiac Structure and Function: The Strong Heart Study
Devereux, R. B., Roman, M. J., Paranicas, M., O’Grady, M. J., Lee, E. T., Welty, T. K., Fabsitz, R. R., Robbins, D., Rhoades, E. R., & Howard, B. V. (2000) · Circulation · doi:10.1161/01.cir.101.19.2271 · Cited by 942
Molecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Self-citationMohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palù, G., & Martines, D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2006 · Cited by 864
Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jørgensen, M. E., Thuresson, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029190 · Cited by 813
The Incidence of Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A., & Brown, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1879 · Cited by 812
Myocardial Cell Death in Human Diabetes
Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B., & Anversa, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1123 · Cited by 796
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., & Taegtmeyer, H. (2004) · The FASEB Journal · doi:10.1096/fj.04-2263com · Cited by 790
van Riet, E. E. S., Hoes, A. W., Wagenaar, K. P., Limburg, A., Landman, M. A. J., & Rutten, F. H. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.483 · Cited by 783
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Self-citationEvidence for Cardiomyopathy in Familial Diabetes Mellitus
Regan, T. J., Lyons, M. M., Ahmed, S. S., Levinson, G. E., Oldewurtel, H. A., Ahmad, M. R., & Haider, B. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108843 · Cited by 728
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Margulies, K. B., Hernandez, A. F., Redfield, M. M., Givertz, M. M., Oliveira, G. H., Cole, R., Mann, D. L., Whellan, D. J., Kiernan, M. S., Felker, G. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.10260 · Cited by 706
Reactive oxygen species (ROS) in macrophage activation and function in diabetes
Rendra, E., Riabov, V., Mossel, D. M., Sevastyanova, T., Harmsen, M. C., & Kzhyshkowska, J. (2019) · Immunobiology · doi:10.1016/j.imbio.2018.11.010 · Cited by 636
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Inflammatory mediators in chronic heart failure: an overview
Anker, S. D., & von Haehling, S. (2004) · Heart · doi:10.1136/hrt.2002.007005 · Cited by 627
Cardiac Steatosis in Diabetes Mellitus: A 1 H-Magnetic Resonance Spectroscopy Study
McGavock, J. M., Lingvay, I., Zib, I., Tillery, T., Salas, N., Unger, R., Levine, B. D., Raskin, P., Victor, R. G., & Szczepaniak, L. S. (2007) · Circulation · doi:10.1161/circulationaha.106.645614 · Cited by 612
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Shah, M. S., & Brownlee, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306923 · Cited by 602
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation
Erickson, J. R., Pereira, L., Wang, L., Han, G., Ferguson, A., Dao, K., Copeland, R. J., Despa, F., Hart, G. W., Ripplinger, C. M., et al. (2013) · Nature · doi:10.1038/nature12537 · Cited by 598
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., et al. (2007) · Diabetes · doi:10.2337/db07-0481 · Cited by 586
Self-citationHyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
Nagareddy, P. R., Murphy, A. J., Stirzaker, R. A., Hu, Y., Yu, S., Miller, R. G., Ramkhelawon, B., Distel, E., Westerterp, M., Huang, L.-S., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.001 · Cited by 577
Buchanan, J., Mazumder, P. K., Hu, P., Chakrabarti, G., Roberts, M. W., Yun, U. J., Cooksey, R. C., Litwin, S. E., & Abel, E. D. (2005) · Endocrinology · doi:10.1210/en.2005-0938 · Cited by 555
Self-citationHuynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Self-citationGalderisi, M., Anderson, K. M., Wilson, P. W. F., & Levy, D. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90716-x · Cited by 552
Boyer, J. K., Thanigaraj, S., Schechtman, K. B., & Pérez, J. E. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.026 · Cited by 534
Heart Failure with Preserved Ejection Fraction
Redfield, M. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1511175 · Cited by 510
Smith, R. A. J., Hartley, R. C., Cochemé, H. M., & Murphy, M. P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.010 · Cited by 499
Xie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., et al. (2011) · Diabetes · doi:10.2337/db10-0351 · Cited by 490
Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes
Di Carli, M. F., Janisse, J., Ager, J., & Grunberger, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00166-9 · Cited by 487
Mills, R. J., Titmarsh, D. M., Koenig, X., Parker, B. L., Ryall, J. G., Quaife-Ryan, G. A., Voges, H. K., Hodson, M. P., Ferguson, C., Drowley, L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707316114 · Cited by 478
Wanner, C., Lachin, J. M., Inzucchi, S. E., Fitchett, D., Mattheus, M., George, J., Woerle, H. J., Broedl, U. C., von Eynatten, M., & Zinman, B. (2018) · Circulation · doi:10.1161/circulationaha.117.028268 · Cited by 469
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Diabetic cardiomyopathy: pathophysiology and clinical features
Miki, T., Yuda, S., Kouzu, H., & Miura, T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9313-3 · Cited by 460
Candido, R., Forbes, J. M., Thomas, M. C., Thallas, V., Dean, R. G., Burns, W. C., Tikellis, C., Ritchie, R. H., Twigg, S. M., Cooper, M. E., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000065620.39919.20 · Cited by 448
Self-citationAnderson, E. J., Kypson, A. P., Rodriguez, E., Anderson, C. A., Lehr, E. J., & Neufer, P. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.031 · Cited by 440
Mazumder, P. K., O’Neill, B. T., Roberts, M. W., Buchanan, J., Yun, U. J., Cooksey, R. C., Boudina, S., & Abel, E. D. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2366 · Cited by 437
Self-citationNassif, M. E., Windsor, S. L., Tang, F., Khariton, Y., Husain, M., Inzucchi, S. E., McGuire, D. K., Pitt, B., Scirica, B. M., Austin, B., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042929 · Cited by 424
Insulin Signaling and Heart Failure
Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 418
Self-citationCanagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1712572 · Cited by 415
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Diabetic Cardiovascular Disease Induced by Oxidative Stress
Kayama, Y., Raaz, U., Jagger, A., Adam, M., Schellinger, I., Sakamoto, M., Suzuki, H., Toyama, K., Spin, J., & Tsao, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025234 · Cited by 407
Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1104 · Cited by 401
Chavez, A. O., Molina-Carrion, M., Abdul-Ghani, M. A., Folli, F., DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-0684 · Cited by 390
Widyantoro, B., Emoto, N., Nakayama, K., Anggrahini, D. W., Adiarto, S., Iwasa, N., Yagi, K., Miyagawa, K., Rikitake, Y., Suzuki, T., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.938217 · Cited by 385
Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy
Shen, X., Zheng, S., Metreveli, N. S., & Epstein, P. N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1039 · Cited by 378
Thrainsdottir, I. S., Aspelund, T., Thorgeirsson, G., Gudnason, V., Hardarson, T., Malmberg, K., Sigurdsson, G., & Rydén, L. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.612 · Cited by 374
Katare, R., Caporali, A., Zentilin, L., Avolio, E., Sala‐Newby, G. B., Oikawa, A., Cesselli, D., Beltrami, A. P., Giacca, M., Emanueli, C., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.239111 · Cited by 373
Diamant, M., Lamb, H. J., Groeneveld, Y., Endert, E. L., Smit, J. W. A., Bax, J. J., Romijn, J. A., de Roos, A., & Radder, J. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00625-9 · Cited by 372
Mazer, C. D., Hare, G. M. T., Connelly, P. W., Gilbert, R. E., Shehata, N., Quan, A., Teoh, H., Leiter, L. A., Zinman, B., Jüni, P., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044235 · Cited by 371
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
Vinik, A. I., Erbas, T., & Casellini, C. M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12042 · Cited by 371
Echocardiographic detection of early diabetic myocardial disease
Fang, Z. Y., Yuda, S., Anderson, V., Short, L., Case, C., & Marwick, T. H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02869-3 · Cited by 369
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Marwick, T. H., Ritchie, R., Shaw, J. E., & Kaye, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.019 · Cited by 365
Self-citationCefalu, W. T., Kaul, S., Gerstein, H. C., Holman, R. R., Zinman, B., Skyler, J. S., Green, J. B., Buse, J. B., Inzucchi, S. E., Leiter, L. A., et al. (2018) · Diabetes Care · doi:10.2337/dci17-0057 · Cited by 363
Diabetic cardiomyopathy - A comprehensive updated review
Murtaza, G., Virk, H. U. H., Khalid, M., Lavie, C. J., Ventura, H., Mukherjee, D., Ramu, V., Bhogal, S., Kumar, G., Shanmugasundaram, M., et al. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.03.003 · Cited by 358
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution
Niemann, B., Rohrbach, S., Miller, M. R., Newby, D. E., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.043 · Cited by 353
Lipid Use and Misuse by the Heart
Schulze, P. C., Drosatos, K., & Goldberg, I. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.306842 · Cited by 352
Kosiborod, M. N., Jhund, P. S., Docherty, K. F., Diez, M., Petrie, M. C., Verma, S., Nicolau, J. C., Merkely, B., Kitakaze, M., DeMets, D. L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044138 · Cited by 350
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Thomas, M. C., & Cherney, D. Z. I. (2018) · Diabetologia · doi:10.1007/s00125-018-4669-0 · Cited by 348
Wang, Y., Fan, P., & Kahaleh, B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21948 · Cited by 347
van Hoeven, K. H., & Factor, S. M. (1990) · Circulation · doi:10.1161/01.cir.82.3.848 · Cited by 342
Duggirala, R., Blangero, J., Almasy, L., Dyer, T. D., Williams, K. L., Leach, R. J., O'Connell, P., & Stern, M. P. (1999) · The American Journal of Human Genetics · doi:10.1086/302316 · Cited by 337
Chou, E., Suzuma, I., Way, K. J., Opland, D., Clermont, A. C., Naruse, K., Suzuma, K., Bowling, N. L., Vlahos, C. J., Aiello, L. P., et al. (2002) · Circulation · doi:10.1161/hc0302.102143 · Cited by 337
Singh, V. P., Le, B., Khode, R., Baker, K. M., & Kumar, R. (2008) · Diabetes · doi:10.2337/db08-0805 · Cited by 332
Tsushima, K., Bugger, H., Wende, A. R., Soto, J., Jenson, G. A., Tor, A. R., McGlauflin, R., Kenny, H. C., Zhang, Y., Souvenir, R., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311307 · Cited by 330
Self-citationKwong, R. Y., Sattar, H., Wu, H., Vorobiof, G., Gandla, V., Steel, K., Siu, S., & Brown, K. A. (2008) · Circulation · doi:10.1161/circulationaha.107.727826 · Cited by 329
Mizushige, K., Yao, L., Noma, T., Kiyomoto, H., Yu, Y., Hosomi, N., Ohmori, K., & Matsuo, H. (2000) · Circulation · doi:10.1161/01.cir.101.8.899 · Cited by 326
Montaigne, D., Marechal, X., Coisne, A., Debry, N., Modine, T., Fayad, G., Potelle, C., El Arid, J.-M., Mouton, S., Sebti, Y., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.008476 · Cited by 322
Tan, Z. B., Elo, T., Puska, A., Sarkar, J., Lähteenmäki, P., Duerr, F., Gould, C., Molenkamp, L. W., Nagaev, K. E., & Hakonen, P. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32777-5 · Cited by 316
FGF21 as Modulator of Metabolism in Health and Disease
Tezze, C., Romanello, V., & Sandri, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00419 · Cited by 315
Dunlay, S. M., Roger, V. L., Weston, S. A., Jiang, R., & Redfield, M. M. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.966366 · Cited by 312
Mills, R. J., Parker, B. L., Quaife-Ryan, G. A., Voges, H. K., Needham, E. J., Bornot, A., Ding, M., Andersson, H., Polla, M., Elliott, D. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.009 · Cited by 312
Boudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.792101 · Cited by 301
Self-citationCardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Faria, A., & Persaud, S. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.013 · Cited by 295
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
Gilbert, R. E., & Krum, H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61402-1 · Cited by 293
Lind, M., Bounias, I., Olsson, M., Gudbjörnsdottir, S., Svensson, A.-M., & Rosengren, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60471-6 · Cited by 292
Vrhovac, I., Balen Eror, D., Klessen, D., Burger, C., Breljak, D., Kraus, O., Radović, N., Jadrijević, S., Aleksic, I., Walles, T., et al. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1619-7 · Cited by 290
Diabetes Mellitus Induces Changes in Cardiac Myosin of the Rat
Dillmann, W. H. (1980) · Diabetes · doi:10.2337/diab.29.7.579 · Cited by 288
Yoon, Y.-S., Uchida, S., Masuo, O., Cejna, M., Park, J.-S., Gwon, H.-C., Kirchmair, R., Bahlman, F., Walter, D., Curry, C., et al. (2005) · Circulation · doi:10.1161/01.cir.0000162472.52990.36 · Cited by 288
Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors
Scheen, A. J. (2018) · Circulation Research · doi:10.1161/circresaha.117.311588 · Cited by 286
Rodent models of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001941 · Cited by 285
Self-citationMraz, M., Bartlova, M., Lacinova, Z., Michalsky, D., Kasalicky, M., Haluzikova, D., Matoulek, M., Dostalova, I., Humenanska, V., & Haluzik, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03502.x · Cited by 279
Ohkuma, T., Komorita, Y., Peters, S. A. E., & Woodward, M. (2019) · Diabetologia · doi:10.1007/s00125-019-4926-x · Cited by 279
Zabalgoitia, M., Ismaeil, M. F., Anderson, L., & Maklady, F. A. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01366-7 · Cited by 279
Catalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes
Ye, G., Metreveli, N. S., Donthi, R. V., Xia, S., Xu, M., Carlson, E. C., & Epstein, P. N. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1336 · Cited by 279
Westermann, D., Rutschow, S., Jäger, S., Linderer, A., Anker, S., Riad, A., Unger, T., Schultheiss, H.-P., Pauschinger, M., & Tschöpe, C. (2007) · Diabetes · doi:10.2337/db06-1163 · Cited by 273
Diagnostic approaches for diabetic cardiomyopathy
Lorenzo-Almorós, A., Tuñón, J., Orejas, M., Cortés, M., Egido, J., & Lorenzo, Ó. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0506-x · Cited by 263
Gustafsson, I., Brendorp, B., Seibæk, M., Burchardt, H., Hildebrandt, P., Køber, L., & Torp-Pedersen, C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.024 · Cited by 258
Ouwens, D. M., Boer, C., Fodor, M., de Galan, P., Heine, R. J., Maassen, J. A., & Diamant, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1755-x · Cited by 256
Mechanisms of [Ca2+]i Transient Decrease in Cardiomyopathy of db/db Type 2 Diabetic Mice
Pereira, L., Matthes, J., Schuster, I., Valdivia, H. H., Herzig, S., Richard, S., & Gómez, A. M. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1284 · Cited by 256
Decreased Sarcoplasmic Reticulum Activity and Contractility in Diabetic db/db Mouse Heart
Belke, D. D., Swanson, E. A., & Dillmann, W. H. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3201 · Cited by 252
Depressed cardiac sarcoplasmic reticular function from diabetic rats
Penpargkul, S. (1981) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(81)90318-7 · Cited by 251
Collagen remodelling in myocardia of patients with diabetes.
Shimizu, M., Umeda, K., Sugihara, N., Yoshio, H., Ino, H., Takeda, R., Okada, Y., & Nakanishi, I. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.1.32 · Cited by 247
McFarlane, S. I., Kumar, A., & Sowers, J. R. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00432-6 · Cited by 245
Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans
Fröjdö, S., Vidal, H., & Pirola, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.019 · Cited by 245
Small Nucleolar RNAs U32a, U33, and U35a Are Critical Mediators of Metabolic Stress
Michel, C. I., Holley, C. L., Scruggs, B. S., Sidhu, R., Brookheart, R. T., Listenberger, L. L., Behlke, M. A., Ory, D. S., & Schaffer, J. E. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.009 · Cited by 243
Mariappan, N., Elks, C. M., Sriramula, S., Guggilam, A., Liu, Z., Borkhsenious, O., & Francis, J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp305 · Cited by 240
Zarich, S. W., Arbuckle, B. E., Cohen, L. R., Roberts, M., & Nesto, R. W. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90364-6 · Cited by 239
Li, L., Li, S., Deng, K., Liu, J., Vandvik, P. O., Zhao, P., Zhang, L., Shen, J., Bala, M. M., Sohani, Z. N., et al. (2016) · BMJ · doi:10.1136/bmj.i610 · Cited by 238
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
Greco, S., Fasanaro, P., Castelvecchio, S., D’Alessandra, Y., Arcelli, D., Di Donato, M., Malavazos, A., Capogrossi, M. C., Menicanti, L., & Martelli, F. (2012) · Diabetes · doi:10.2337/db11-0952 · Cited by 234
Lincoff, A. M., Tardif, J.-C., Schwartz, G. G., Nicholls, S. J., Rydén, L., Neal, B., Malmberg, K., Wedel, H., Buse, J. B., Henry, R. R., et al. (2014) · JAMA · doi:10.1001/jama.2014.3321 · Cited by 231
Lipids, lysosomes, and autophagy
Jaishy, B., & Abel, E. D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067520 · Cited by 230
Self-citationBidasee, K. R., Zhang, Y., Shao, C. H., Wang, M., Patel, K. P., Dincer, U. D., & Besch, H. R. (2004) · Diabetes · doi:10.2337/diabetes.53.2.463 · Cited by 229
Hu, Y., Belke, D., Suarez, J., Swanson, E., Clark, R., Hoshijima, M., & Dillmann, W. H. (2005) · Circulation Research · doi:10.1161/01.res.0000165478.06813.58 · Cited by 228
Cardiac spheroids as promising in vitro models to study the human heart microenvironment
Polonchuk, L., Chabria, M., Badi, L., Hoflack, J.-C., Figtree, G., Davies, M. J., & Gentile, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-06385-8 · Cited by 223
Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage
Selvin, E., Lazo, M., Chen, Y., Shen, L., Rubin, J., McEvoy, J. W., Hoogeveen, R. C., Sharrett, A. R., Ballantyne, C. M., & Coresh, J. (2014) · Circulation · doi:10.1161/circulationaha.114.010815 · Cited by 223
Heart failure with preserved ejection fraction
Gladden, J. D., Linke, W. A., & Redfield, M. M. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1480-8 · Cited by 218
Calmodulin-induced early-onset diabetes in transgenic mice
Epstein, P. N., Overbeek, P. A., & Means, A. R. (1989) · Cell · doi:10.1016/0092-8674(89)90505-9 · Cited by 215
Sharma, A., Tate, M., Mathew, G., Vince, J. E., Ritchie, R. H., & de Haan, J. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00114 · Cited by 215
Self-citationNLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
Luo, B., Huang, F., Liu, Y., Liang, Y., Wei, Z., Ke, H., Zeng, Z., Huang, W., & He, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00519 · Cited by 213
OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance
Pereira, R. O., Tadinada, S. M., Zasadny, F. M., Oliveira, K. J., Pires, K. M. P., Olvera, A., Jeffers, J., Souvenir, R., Mcglauflin, R., Seei, A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696179 · Cited by 211
Self-citationRequirement for O‐linked N‐acetylglucosaminyltransferase in lymphocytes activation
Golks, A., Tran, T. T., Goetschy, J. F., & Guerini, D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601845 · Cited by 211
Martinez, F. A., Serenelli, M., Nicolau, J. C., Petrie, M. C., Chiang, C.-E., Tereshchenko, S., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044133 · Cited by 210
miR133a regulates cardiomyocyte hypertrophy in diabetes
Feng, B., Chen, S., George, B., Feng, Q., & Chakrabarti, S. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1054 · Cited by 210
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage
Liu, Q., Wang, S., & Cai, L. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12250 · Cited by 206
Hyperglycemia Decreases Glucose Uptake in Type I Diabetes
Yki-Järvinen, H., Helve, E., & Koivisto, V. A. (1987) · Diabetes · doi:10.2337/diab.36.8.892 · Cited by 205
Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multiethnic Population
Eguchi, K., Boden-Albala, B., Jin, Z., Rundek, T., Sacco, R. L., Homma, S., & Di Tullio, M. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.082 · Cited by 199
Unger, E. D., Dubin, R. F., Deo, R., Daruwalla, V., Friedman, J. L., Medina, C., Beussink, L., Freed, B. H., & Shah, S. J. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.445 · Cited by 199
Mellor, K. M., Bell, J. R., Young, M. J., Ritchie, R. H., & Delbridge, L. M. D. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.002 · Cited by 198
Self-citationGu, J., Cheng, Y., Wu, H., Kong, L., Wang, S., Xu, Z., Zhang, Z., Tan, Y., Keller, B. B., Zhou, H., et al. (2017) · Diabetes · doi:10.2337/db15-1274 · Cited by 196
Of mice and men: models and mechanisms of diabetic cardiomyopathy
Riehle, C., & Bauersachs, J. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 196
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
Linthout, S., Seeland, U., Riad, A., Eckhardt, O., Hohl, M., Dhayat, N., Richter, U., Fischer, J. W., Böhm, M., Pauschinger, M., et al. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0715-2 · Cited by 195
Diabetes-associated dysregulation of O -GlcNAcylation in rat cardiac mitochondria
Banerjee, P. S., Ma, J., & Hart, G. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424017112 · Cited by 194
Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
The ACCORD Study Group (2016) · Diabetes Care · doi:10.2337/dc15-2283 · Cited by 193
Mori, J., Patel, V. B., Abo Alrob, O., Basu, R., Altamimi, T., DesAulniers, J., Wagg, C. S., Kassiri, Z., Lopaschuk, G. D., & Oudit, G. Y. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000672 · Cited by 192
Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats
FIORDALISO, F., BIANCHI, R., STASZEWSKY, L., CUCCOVILLO, I., DONI, M., LARAGIONE, T., SALIO, M., SAVINO, C., MELUCCI, S., & SANTANGELO, F. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.07.008 · Cited by 191
Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes
Ren, J., & Davidoff, A. J. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.1.h148 · Cited by 190
Li, S.-Y., Yang, X., Ceylan-Isik, A. F., Du, M., Sreejayan, N., & Ren, J. (2006) · Diabetologia · doi:10.1007/s00125-006-0229-0 · Cited by 187
PI3K and Calcium Signaling in Cardiovascular Disease
Ghigo, A., Laffargue, M., Li, M., & Hirsch, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.310183 · Cited by 184
Bugger, H., Boudina, S., Hu, X. X., Tuinei, J., Zaha, V. G., Theobald, H. A., Yun, U. J., McQueen, A. P., Wayment, B., Litwin, S. E., et al. (2008) · Diabetes · doi:10.2337/db08-0079 · Cited by 182
Self-citationLee, M., Gardin, J. M., Lynch, J. C., Smith, V.-E., Tracy, R. P., Savage, P. J., Szklo, M., & Ward, B. J. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70245-x · Cited by 181
Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
Bugger, H., Chen, D., Riehle, C., Soto, J., Theobald, H. A., Hu, X. X., Ganesan, B., Weimer, B. C., & Abel, E. D. (2009) · Diabetes · doi:10.2337/db09-0259 · Cited by 180
Self-citationSeferović, P. M., Coats, A. J. S., Ponikowski, P., Filippatos, G., Huelsmann, M., Jhund, P. S., Polovina, M. M., Komajda, M., Seferović, J., Sari, I., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1673 · Cited by 178
Wilson, A. J., Gill, E. K., Abudalo, R. A., Edgar, K. S., Watson, C. J., & Grieve, D. J. (2018) · Heart · doi:10.1136/heartjnl-2017-311448 · Cited by 177
Singh, V. P., Baker, K. M., & Kumar, R. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91493.2007 · Cited by 176
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
Galderisi, M. (2005) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-3-9 · Cited by 175
Ernande, L., Rietzschel, E. R., Bergerot, C., De Buyzere, M. L., Schnell, F., Groisne, L., Ovize, M., Croisille, P., Moulin, P., Gillebert, T. C., et al. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.09.007 · Cited by 171
Li, J., Zhu, H., Shen, E., Wan, L., Arnold, J. M. O., & Peng, T. (2010) · Diabetes · doi:10.2337/db09-1800 · Cited by 171
Zhang, H., Chen, X., Zong, B., Yuan, H., Wang, Z., Wei, Y., Wang, X., Liu, G., Zhang, J., Li, S., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13743 · Cited by 171
Miyake, K., Ogawa, W., Matsumoto, M., Nakamura, T., Sakaue, H., & Kasuga, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15880 · Cited by 170
Lehman, D. M., Fu, D.-J., Freeman, A. B., Hunt, K. J., Leach, R. J., Johnson-Pais, T., Hamlington, J., Dyer, T. D., Arya, R., Abboud, H., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1214 · Cited by 169
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction
Cook, S. A., Varela-Carver, A., Mongillo, M., Kleinert, C., Khan, M. T., Leccisotti, L., Strickland, N., Matsui, T., Das, S., Rosenzweig, A., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp396 · Cited by 169
Figtree, G. A., Rådholm, K., Barrett, T. D., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Matthews, D. R., Shaw, W., & Neal, B. (2019) · Circulation · doi:10.1161/circulationaha.119.040057 · Cited by 164
Aragón-Herrera, A., Feijóo-Bandín, S., Otero Santiago, M., Barral, L., Campos-Toimil, M., Gil-Longo, J., Costa Pereira, T. M., García-Caballero, T., Rodríguez-Segade, S., Rodríguez, J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113677 · Cited by 163
Class effects of SGLT2 inhibitors on cardiorenal outcomes
Kluger, A. Y., Tecson, K. M., Lee, A. Y., Lerma, E. V., Rangaswami, J., Lepor, N. E., Cobble, M. E., & McCullough, P. A. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0903-4 · Cited by 162
Anderson, E. J., Rodriguez, E., Anderson, C. A., Thayne, K., Chitwood, W. R., & Kypson, A. P. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00932.2010 · Cited by 161
Huynh, K., McMullen, J. R., Julius, T. L., Tan, J. W., Love, J. E., Cemerlang, N., Kiriazis, H., Du, X., & Ritchie, R. H. (2010) · Diabetes · doi:10.2337/db09-1456 · Cited by 161
Self-citationBasu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., & Kassiri, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00452.2009 · Cited by 161
Huynh, K., Kiriazis, H., Du, X.-J., Love, J. E., Jandeleit-Dahm, K. A., Forbes, J. M., McMullen, J. R., & Ritchie, R. H. (2012) · Diabetologia · doi:10.1007/s00125-012-2495-3 · Cited by 161
Self-citationDynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis
Groves, J. A., Lee, A., Yildirir, G., & Zachara, N. E. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0426-y · Cited by 160
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Hölscher, M., Bode, C., & Bugger, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122136 · Cited by 160
Dinh, W., Füth, R., Nickl, W., Krahn, T., Ellinghaus, P., Scheffold, T., Bansemir, L., Bufe, A., Barroso, M. C., & Lankisch, M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-58 · Cited by 159
Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats
Lagadic-Gossmann, D., Buckler, K. J., Le Prigent, K., & Feuvray, D. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1529 · Cited by 159
O‐GlcNAcylation of TAB1 modulates TAK1‐mediated cytokine release
Pathak, S., Borodkin, V. S., Albarbarawi, O., Campbell, D. G., Ibrahim, A. F. M., & van Aalten, D. M. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.8 · Cited by 158
SIMONE, G. D., Devereux, R. B., Chinali, M., Lee, E. T., Galloway, J. M., Barac, A., Panza, J. A., & Howard, B. V. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283331169 · Cited by 157
Westermann, D., Rutschow, S., Linthout, S. V., Linderer, A., Bücker-Gärtner, C., Sobirey, M., Riad, A. H., Pauschinger, M., Schultheiß, H., & Tschöpe, C. (2006) · Diabetologia · doi:10.1007/s00125-006-0385-2 · Cited by 156
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology
Beale, A. L., Nanayakkara, S., Segan, L. A., Mariani, J. A., Maeder, M. T., van Empel, V. P. M., Vizi, D., Evans, S., Lam, C. S. P., & Kaye, D. M. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.01.004 · Cited by 155
Durgan, D. J., Pat, B., Laczy, B., Bradley, J. A., Tsai, J.-Y., Grenett, M. H., Ratcliffe, W. F., Brewer, R. A., Nagendran, J., Villegas‐Montoya, C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278903 · Cited by 149
TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
Ti, Y., Xie, G.-L., Wang, Z., Bi, X., Ding, W., Wang, J., Jiang, G.-H., Bu, P. L., Zhang, Y., Zhong, M., et al. (2011) · Diabetes · doi:10.2337/db11-0549 · Cited by 149
Oltman, C. L., Richou, L. L., Davidson, E. P., Coppey, L. J., Lund, D. D., & Yorek, M. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01297.2005 · Cited by 148
Abnormal cardiac function in the streptozotocin-induced, non–insulin-dependent diabetic rat
Joffe, I. I., Travers, K. E., Perreault-Micale, C. L., Hampton, T., Katz, S. E., Morgan, J. P., & Douglas, P. S. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00436-2 · Cited by 147
Aragno, M., Mastrocola, R., Medana, C., Catalano, M. G., Vercellinatto, I., Danni, O., & Boccuzzi, G. (2006) · Endocrinology · doi:10.1210/en.2006-0728 · Cited by 147
Uric Acid Promotes Left Ventricular Diastolic Dysfunction in Mice Fed a Western Diet
Jia, G., Habibi, J., Bostick, B. P., Ma, L., DeMarco, V. G., Aroor, A. R., Hayden, M. R., Whaley‐Connell, A. T., & Sowers, J. R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04737 · Cited by 145
Jia, G., Habibi, J., DeMarco, V. G., Martinez‐Lemus, L. A., Ma, L., Whaley‐Connell, A. T., Aroor, A. R., Domeier, T. L., Zhu, Y., Meininger, G. A., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06015 · Cited by 145
MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice
Zhang, M., Zhang, L., Hu, J., Lin, J. M., Wang, T., Duan, Y., Man, W., Feng, J., Sun, L., Jia, H., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4070-9 · Cited by 145
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study
Cahn, A., Mosenzon, O., Wiviott, S. D., Rozenberg, A., Yanuv, I., Goodrich, E. L., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1476 · Cited by 145
Cited by
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Self-citationDiabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Self-citationYang, D.-R., Wang, M.-Y., Zhang, C.-L., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359255 · Cited by 280
Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., Matsuo, N., Ichikawa, K., Iwasaki, K., Naito, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073587 · Cited by 268
The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74
Metadata
- Authors
- Ritchie, R. H., & Abel, E. D.
- Venue
- Circulation Research
- Published
- 2020-05-22
- Volume
- 126
- Issue
- 11
- Pages
- 1501-1525
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3026907472
- Cited by
- 708
- References
- 369
- FWCI
- 38.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.